Cargando…
Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol
BACKGROUND: Celastrol is a novel anti-tumor agent. Ways to further enhance this effect of celastrol has attracted much research attention. METHODS AND RESULTS: Here, we report that celastrol treatment can elevate miR-223 in human breast cancer cell line MCF-7 and prostate cancer PC3. Down-regulating...
Autores principales: | Cao, Lu, Zhang, Xue, Cao, Fanfan, Wang, Ying, Shen, Yufan, Yang, Chunxin, Uzan, Georges, Peng, Bin, Zhang, Denghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640397/ https://www.ncbi.nlm.nih.gov/pubmed/26552919 http://dx.doi.org/10.1186/s12885-015-1909-2 |
Ejemplares similares
-
HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way
por: Peng, Bin, et al.
Publicado: (2010) -
Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells
por: Peng, Bin, et al.
Publicado: (2014) -
Celastrol Treatment Ameliorated Acute Ischemic Stroke-Induced Brain Injury by Microglial Injury Inhibition and Nrf2/HO-1 Pathway Activations
por: Cao, Fanfan, et al.
Publicado: (2023) -
Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization
por: Jiang, Mei, et al.
Publicado: (2018) -
The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells
por: Wang, Lijun, et al.
Publicado: (2021)